Aptamers Market Trends

Aptamers Market Trends

The increasing prevalence of chronic and rare diseases will boost the industry gains. For instance, according to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. alone. As the burden of these conditions continues to rise, the demand for innovative and targeted therapeutic solutions becomes increasingly urgent. Therefore, aptamers, with versatile nature enables the development of precision therapies tailored to the unique characteristics of each ailment, paving the way for more effective treatment strategies. Also, the flexibility of aptamers in targeting diverse disease markers, enable to opt for precision medicine approaches.